Search results
Panorama T4 and T6 are advanced Panorama-class performance MIDI controllers with full VST/AU instrument plugin control in any DAW, 2nd Gen keyboard with 49 or 61 keys, aftertouch, note repeat, great pads and Nektar DAW Integration.
Nektar (German for nectar) is an English progressive rock band formed in Hamburg, West Germany in 1969, by guitarist and lead vocalist Roye Albrighton, keyboardist Allan "Taff" Freeman, bassist Derek "Mo" Moore, and drummer Ron Howden.
Incredible value included with select keyboards Any purchase of a new Impact LX Mini, LX25/49/61/88+, GXP49/61/88 or Panorama T4/T6 now includes 5 fantastic Cherry Audio plugins. Learn more.
Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs.
Fun and expressive to play: The SE49's synth-action keybed has 49 velocity-sensitive full-size keys with a defined and firm feel. What's more, a choice of 4 different velocity curves (plus 3 fixed ones) allows you to adjust the keyboard response to your needs.
The Nektar SE49 and SE61USB MIDI controller keyboards have all the features you need to start making music with your computer. The SE Series is compatible with any MIDI music software, sports a full-size keyboard with velocity, includes all the performance controls you’d expect and even has Nektar DAW control features.
Keep me logged in (Not advised for public computers) Login OR. Sign in with Google Sign in with Microsoft
Nektar were originally a group of British musicians living and working together near Heidelberg in Southern Germany during the early to mid seventies. They had massive success both with their albums and their live shows, which were famous for an adventurous mixture of good live-sound and vision, due to the light show covering the band during ...
General tips and tricks to help with getting started with your Nektar platform. By Martin and 6 others94 articles.
R&D Pipeline. Nektar Therapeutics has a targeted portfolio of novel therapeutics that target cytokine pathways and other mechanisms to selectively modulate the immune system and to advance the treatment of autoimmune disorders, chronic inflammatory conditions and cancer.
